Insight Express: Your FAST Insight
IQVIA experts explore a new industry hot topic in under two minutes
Feature 1: The 340B Program
The 340B Drug Pricing Program is a rapidly expanding federal initiative in which manufacturers offer discounted medicines to eligible hospitals and clinics. Its scale, complexity, and limited transparency have made it a frequent source of debate within the healthcare system. As costs continue to rise, understanding how 340B operates—and who it impacts, remains essential for stakeholders across the healthcare landscape, from policymakers and manufacturers to providers and patients.
Speaker: Rory Martin, PhD, Sr. Principal, Market Access Technology Solutions, IQVIA
Feature 2: 340B Growth
Discussions about 340B have long centered on the program’s overall size, with far less attention given to where growth is happening. In practice, that growth is highly uneven and is concentrated in a limited set of complex therapeutic areas such as oncology, immunology, and cardiometabolic disease. These categories represent some of the highest‑utilization and fastest‑growing segments of the market, driving a disproportionate share of 340B expansion.
Speaker: Shanyue Zeng, Data Scientist, Market Access Technology Solutions, IQVIA
Feature 3: Who are 340B Patients?
The 340B Program was established to help safety‑net hospitals and clinics better support low‑income and uninsured patients without relying on federal funding. Today, questions about how 340B revenue is generated and used have made transparency increasingly important. Clearer insight into how revenue is generated would enable patients, health plans, and policymakers to understand the programs true impact better—and assess whether its resources are ultimately benefiting patients care.
Speaker: Chuan Sun, Manager, Market Access Technology Solutions, IQVIA
Related solutions
Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance.
Grow your brand, now and through patent expiry
Gain high value access and increase the profitability of your brands